Immunotherapy for pancreatic cancer: A 2020 update - Cancer Treatment Reviews
Pancreatic Cancer Vaccine: What to Know | Johns Hopkins Medicine
CAR-T cells clinical trials* against pancreatic cancer | Download Table
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? | Oncotarget
From bench to bedside a comprehensive review of pancreatic cancer immunotherapy | Journal for ImmunoTherapy of Cancer
Pancreatic cancer vaccine: a unique potential therapy | GICTT
Immunotherapy in pancreatic cancer treatment: a new frontier - Komal Thind, Leslie J. Padrnos, Ramesh K. Ramanathan, Mitesh J. Borad, 2017
Frontiers | Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies | Immunology
Pancreatic Cancer Vaccine: What to Know | Johns Hopkins Medicine
RNA vaccine for melanoma shows promise in early clinical trial
Pancreatic Cancer IO Landscape - Cancer Research Institute (CRI)
Cabozantinib + Atezolizumab for Cancer of Pancreas Clinical Trial 2022 | Power
Advances in Immunotherapy for Pancreatic Cancer: 2013
Pancreatic Cancer Vaccine: What to Know | Johns Hopkins Medicine
The dark side of immunotherapy: pancreatic cancer
Recent advances in immunotherapy for pancreatic cancer
Timeline for the clinical development of the pancreatic cancer patient... | Download Scientific Diagram
Cancers | Free Full-Text | Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy | HTML
Turning the corner on therapeutic cancer vaccines | npj Vaccines
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text
Role of immune cells in pancreatic cancer from bench to clinical application: An updated review. - Abstract - Europe PMC
Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory | Cancer Cell International | Full Text
Cumulative numbers of cancer vaccine clinical trials for each cancer... | Download Scientific Diagram
Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer - ScienceDirect
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial - The Lancet Oncology
Targovax's Pancreatic Cancer Vaccine Gets Another Clinical Success
